Improving Health Literacy in African-American Prostate Cancer Patients
This study aims to improve how African-American men with newly diagnosed, early-stage prostate cancer understand their treatment options and side effects. Researchers are comparing two ways of providing information: standard education from your doctor, and an additional educational supplement (using models and props during a face-to-face interview). The goal is to see if the educational supplement helps you feel more confident in your treatment decisions and better understand your condition. You may be eligible if you are an African-American man between 25 and 100 years old with early-stage prostate cancer diagnosed at Emory University, Grady Memorial Hospital, Saint Joseph's Hospital, or Atlanta VA Medical Center. The study is looking for 210 participants.
- Study design
- This is an interventional study comparing two types of education for prostate cancer patients. It plans to enroll 210 participants.
- What's involved
- You will receive either standard education or an additional educational supplement through a 45-60 minute interview. You will be asked about medical terms and treatments.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your understanding and decision-making will be measured at the beginning of the study and again up to 6 weeks after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Health Literacy in African-American Prostate Cancer Patients
At a glance
Conditions
Where it's being run
4 sites across 1 statesStudy leadership
- Kerry Kilbridge, MD · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Decisional Conflict Scale ScoreBaseline, Post-Intervention (Up to 6 Weeks)
The decisional conflict scale measures personal perceptions of : a) uncertainty in choosing options; b) modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and c) effective decision making such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).
- Change in Comprehension of Treatment Options Score assessed by InterviewBaseline, Post-Intervention (Up to 6 Weeks)
Comprehension of treatment options will be scored as dichotomous variables, correct or incorrect. The changes in the proportion of patients who correctly understand treatment after standard practice compared to the proportion who correctly understand treatment after the low literacy supplement will be analyzed.
- Change in Comprehension of Side Effects Score assessed by InterviewBaseline, Post-Intervention (Up to 6 Weeks)
Comprehension of side effects will be scored as dichotomous variables, correct or incorrect. The changes in the proportion of patients who correctly understand side effects after standard practice compared to the proportion who correctly understand treatment after the low literacy supplement will be analyzed.